Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin E (IgE) is a class of antibody found exclusively in mammals. It plays a central role in allergic reactions and defense against certain parasitic infections. IgE mediates immediate hypersensitivity reactions, commonly known as type I hypersensitivity, which underlie most allergic diseases. IgE contributes to immune defense against helminthic parasites and may also play roles against protozoan parasites. Medications targeting the effects or production of IgE help manage conditions where excessive or inappropriate activation via the IgE pathway leads to disease manifestations.
Monoclonal antibodies neutralize circulating IgE; antihistamines/antileukotrienes block downstream mediators; corticosteroids suppress broad inflammation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin E (IgE).